Глобальна гаряча лінія для українських пацієнтів-біженців, які беруть участь у клінічному випробуванні Amgen. Натисніть тут для отримання додаткової інформації.
Глобальная горячая линия для украинских пациентов-беженцев, участвующих в клиническом исследовании Amgen. Для получения дополнительной информации нажмите здесь.
Press Release 08.04.2022
Leadership 07.28.2022
Patients 07.27.2022
Amgen employee Page Buchanan thought the packaging for an arthritis medicine could be easier to open, so she decided to find a solution.
People & Culture 07.19.2022
A pandemic, shifting priorities and new opportunities for people have changed where, how and why they work. A look at some Amgen employees who considered those things and decided to stay.
Science & Innovation 07.18.2022
Amgen’s Head of U.S. Value & Access, Jen Norton, Previews Amgen’s 2022 Trends in Biosimilars Report
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
